(6R-trans)-7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid CAS:30246-33-4
(6R-trans)-7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid, also known as [insert trade or generic name if applicable], holds significant importance in pharmaceutical research and drug development due to its antibiotic properties. This compound serves as a key building block for the synthesis of antibacterial agents designed to target specific bacterial strains and inhibit their growth. Its structural configuration allows for precise interactions with bacterial enzymes, disrupting essential processes and leading to bactericidal effects. Moreover, (6R-trans)-7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid plays a crucial role in combating bacterial infections that pose a threat to human health. By incorporating this compound into antibiotic formulations, researchers aim to develop novel therapeutic options with enhanced efficacy and reduced resistance. The compound's mechanism of action targets bacterial cell walls or protein synthesis, offering a broad spectrum of activity against both Gram-positive and Gram-negative bacteria, including multidrug-resistant strains. Furthermore, research efforts focus on optimizing the pharmacokinetic properties of (6R-trans)-7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid to improve its bioavailability and distribution within the body. This optimization process involves exploring various drug delivery strategies, such as prodrugs, nanoparticles, or liposomal formulations, to enhance the compound's therapeutic potential and minimize side effects. In conclusion, (6R-trans)-7-amino-3-[[(5-methyl-1,3,4-thiadiazol-2-yl)thio]methyl]-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid represents a valuable asset in the realm of infectious disease treatment, offering promising solutions for addressing bacterial resistance and improving patient outcomes. Its versatile applications in antibiotic therapy underscore its significance in modern medicine and highlight its potential to drive innovation in the development of next-generation antibiotics.
Composition | C11H12N4O3S3 |
Assay | 99% |
Appearance | white powder |
CAS No. | 30246-33-4 |
Packing | Small and bulk |
Shelf Life | 2 years |
Storage | Store in cool and dry area |
Certification | ISO. |